ADVB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ADVB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Advanced Biomed Inc ADVB
Advanced Biomed ADVB +3.10% 12 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ADVB with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 203 Medical Diagnostics & Research companies, Advanced Biomed ranks worse than 492610.34% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Advanced Biomed's Free Cash Flow for the three months ended in Mar. 2026 was $-0.24 Mil. Advanced Biomed's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Advanced Biomed's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
As of today, Advanced Biomed's current FCF Yield % is -35.15%.
The historical rank and industry rank for Advanced Biomed's FCF Margin % or its related term are showing as below:
The historical data trend for Advanced Biomed's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Advanced Biomed Annual Data | |||||||||||
| Trend | Jun21 | Jun22 | Jun23 | Jun24 | Jun25 | ||||||
| FCF Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Advanced Biomed Quarterly Data | |||||||||||||||||
| Jun21 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| FCF Margin % | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
For the Diagnostics & Research subindustry, Advanced Biomed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Advanced Biomed's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Advanced Biomed's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Advanced Biomed's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as
| FCF Margin | = | Free Cash Flow (A: Jun. 2025 ) | / | Revenue (A: Jun. 2025 ) |
| = | -5.857 | / | 0 | |
| = | % |
Advanced Biomed's FCF Margin for the quarter that ended in Mar. 2026 is calculated as
| FCF Margin | = | Free Cash Flow (Q: Mar. 2026 ) | / | Revenue (Q: Mar. 2026 ) |
| = | -0.241 | / | 0 | |
| = | % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.